Modafinil: the unique properties of a new stimulant.

Modafinil, a novel stimulant which has several remarkable features that distinguish it from other stimulants, has been developed by Lafon, a French pharmaceutical company. Unlike the amphetamines, for example, modafinil is reported to have minimal peripheral side effects at therapeutic doses. It also appears to have a low abuse potential, does not interfere with normal sleep, and does not seem to produce tolerance. It improves vigilance especially in sleep-deprived subjects. It has been used clinically for up to 3 years in the treatment of narcolepsy and idiopathic hypersomnia. It could be an ideal replacement for amphetamine in short-term operations in which fatigue might threaten the successful completion of a mission. We recommend that military laboratories experienced in studying sustained performance include modafinil or perhaps a more selective alpha 1 receptor agonist in their investigations.

[1]  D. L. Reeves,et al.  Sustained/Continuous Operations Subgroup of the Department of Defense Human Factors Engineering Technical Group. Program Summary and Abstracts from the Semiannual Meeting (8th). , 1989 .

[2]  M. Jouvet,et al.  Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  Lloyd C. Miller,et al.  USAN and the USP Dictionary of Drug Names , 1981 .

[4]  Senechal Pk.  Flight surgeon support of combat operations at RAF Upper Heyford. , 1988 .

[5]  B. Saletu,et al.  Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (adrafinil) in elderlies. , 1986 .

[6]  F. Goldenberg.  Mise au point d'un indice EEG de vigilance diurne. Application aux essais pharmacologiques , 1986 .

[7]  B. Saletu,et al.  On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  C. Rozé,et al.  EFFECT OF MODAFINIL ON PANCREATIC EXOCRINE SECRETION IN RATS. A COMPARISON WITH ADRAFINIL AND RELATED DRUGS , 1987, Fundamental & clinical pharmacology.

[9]  P K Senechal,et al.  Flight surgeon support of combat operations at RAF Upper Heyford. , 1988, Aviation, space, and environmental medicine.

[10]  A N Nicholson.  Long-range air capability and the South Atlantic Campaign. , 1984, Aviation, space, and environmental medicine.

[11]  P. Anderer,et al.  Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers. , 1989, International journal of clinical pharmacology research.